BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28131747)

  • 1. MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.
    Zhao L; Liu Y; Tong D; Qin Y; Yang J; Xue M; Du N; Liu L; Guo B; Hou N; Han J; Liu S; Liu N; Zhao X; Wang L; Chen Y; Huang C
    EBioMedicine; 2017 Feb; 16():87-100. PubMed ID: 28131747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG-binding protein 2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells through regulating forkhead box F1/Wnt/β-Catenin axis.
    Ji W; Sun X
    Bioengineered; 2022 Jan; 13(1):583-592. PubMed ID: 34967263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
    Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
    Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect.
    Tong D; Zhao L; He K; Sun H; Cai D; Ni L; Sun R; Chang S; Song T; Huang C
    Oncotarget; 2016 Jun; 7(23):34845-59. PubMed ID: 27166996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells.
    Qin Y; Zhao L; Wang X; Tong D; Hoover C; Wu F; Liu Y; Wang L; Liu L; Ni L; Song T; Huang C
    Glycobiology; 2017 Apr; 27(4):306-317. PubMed ID: 28100567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer.
    Wada R; Akiyama Y; Hashimoto Y; Fukamachi H; Yuasa Y
    Int J Cancer; 2010 Sep; 127(5):1106-14. PubMed ID: 20020497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
    Liu X; Long Z; Cai H; Yu S; Wu J
    Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.
    Guo B; Cai S; Li W; Guo C; Liu Y; Ma X; Ma H; Zhao L
    Curr Cancer Drug Targets; 2022; 22(5):414-425. PubMed ID: 35209822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer.
    Zheng L; Kang L; Cheng Y; Cao J; Liu L; Xu H; Gao L
    Pathol Oncol Res; 2021; 27():581542. PubMed ID: 34385891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 attenuates cardiomyocyte hypoxia/reperfusion-induced injury via regulation of the SFRP4/Wnt/β-catenin axis.
    Li N; Zhang T; He M; Mu Y
    Biomarkers; 2021 Jun; 26(4):363-370. PubMed ID: 33726573
    [No Abstract]   [Full Text] [Related]  

  • 13. BARX1 repressed FOXF1 expression and activated Wnt/β-catenin signaling pathway to drive lung adenocarcinoma.
    Guan X; Liang J; Xiang Y; Li T; Zhong X
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129717. PubMed ID: 38290639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
    Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
    Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway.
    Zhou Y; Wang Y; Wen J; Zhao H; Dong X; Zhang Z; Wang S; Shen L
    Oncotarget; 2016 Mar; 7(13):16529-41. PubMed ID: 26918728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXF1 Regulates Alveolar Epithelial Morphogenesis through Transcriptional Activation of Mesenchymal WNT5A.
    Reza AA; Kohram F; Reza HA; Kalin TR; Kannan PS; Zacharias WJ; Kalinichenko VV
    Am J Respir Cell Mol Biol; 2023 Apr; 68(4):430-443. PubMed ID: 36542853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl-CpG Binding Protein 2 as a Potential Diagnostic and Prognostic Marker Facilitates Glioma Progression Through Activation of Wnt/β-Catenin Pathway.
    Huang G; Wu Y; Du Y; Gan H; Hao S
    World Neurosurg; 2023 Mar; 171():e560-e571. PubMed ID: 36529430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells.
    Wu F; Qin Y; Jiang Q; Zhang J; Li F; Li Q; Wang X; Gao Y; Miao J; Guo C; Yang Y; Ni L; Liu L; Zhang S; Huang C
    Cancer Gene Ther; 2020 Nov; 27(10-11):773-784. PubMed ID: 31831855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.